Anti-HIV activity of drugs that stimulate cholesterol efflux by Morrow, Matthew P et al.
BioMed  Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open Access Poster presentation
Anti-HIV activity of drugs that stimulate cholesterol efflux
Matthew P Morrow*, Zahedi A Mujawar and Michael I Bukrinsky
Address: Department of Microbiology and Tropical Medicine, The George Washington University, Washington District of Columbia, 20037, USA
* Corresponding author    
Background
HIV-1 infectivity depends on free cholesterol incorpo-
rated into the viral envelope. Here, we analyze HIV infec-
tivity in the presence of drugs that stimulate cholesterol
efflux.
Materials and methods
Human MDMs and human PBLs were isolated from
healthy, HIV-negative donors and infected with different
HIV-1 variants in the presence or absence of the LXR ago-
nist TO-901317 or the PPAR gamma agonist Pioglitazone.
Infectivity of the virus was measured by FACS using
Ghost-Hi5 cells.
Results
TO-901317 inhibited the spread of HIV in MDM cultures
by 90% at the peak dose (500 nM) and infection of PBLs
by 70%. Pioglitazone inhibited HIV infection by 50% in
both MDM and PBL cultures at 1 M. Analysis of HIV pro-
duced from cells treated with each drug showed reduced
cholesterol content. Reduction in infectivity correlated
with reduction of viral cholesterol. Therefore, drugs stim-
ulating cholesterol efflux reduce HIV infectivity by target-
ing viral cholesterol.
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